BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $605,000 | +3.8% | 4,000 | 0.0% | 0.26% | +13.3% |
| Q2 2022 | $583,000 | +23.0% | 4,000 | 0.0% | 0.23% | +49.4% |
| Q1 2022 | $474,000 | -14.0% | 4,000 | 0.0% | 0.16% | -7.1% |
| Q4 2021 | $551,000 | -0.9% | 4,000 | 0.0% | 0.17% | -8.2% |
| Q3 2021 | $556,000 | +43.3% | 4,000 | 0.0% | 0.18% | +45.2% |
| Q2 2021 | $388,000 | +42.1% | 4,000 | 0.0% | 0.13% | +32.6% |
| Q1 2021 | $273,000 | -20.4% | 4,000 | 0.0% | 0.10% | -25.2% |
| Q4 2020 | $343,000 | +31.9% | 4,000 | 0.0% | 0.13% | +16.5% |
| Q3 2020 | $260,000 | -11.0% | 4,000 | 0.0% | 0.11% | -18.0% |
| Q2 2020 | $292,000 | +33.9% | 4,000 | 0.0% | 0.13% | +47.8% |
| Q4 2019 | $218,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |